Gateway 2012: I Holland Limited - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2012: I Holland Limited



Your online Gateway to I Holland Limited in 2012

Meadow Lane, Long Eaton,
Nottingham, NG10 2GD, England
Telephone:+44 (0) 115 972 6153
Fax: +44 (0) 115 973 1789
www.iholland.co.uk

I Holland Americas
1684 Target Court, Suite 3
Fort Myers, FL 33905
web: www.iholland-americas.com
Telephone: 1-800-420-2991
Email: ihollandtools@comcast.net

About I Holland Limited

More than six decades of research, development and investment has established I Holland as the leading supplier of punches and dies to producers of tablets in a variety of sectors.



Our Commitment to understanding the science behind tabletting has led to the development of innovative materials, bespoke tablet/tool design and established quality assurance technology, all supported by unrivalled customer service.

I Holland is now the sole distributor of OTEC DF (Drag Finishing) machines and consumables in North America.

The automated polisher is just one part of our PharmaCare™ 7-Step Process, developed as a professional maintenance and storage program for punches & dies, enabling you to get the most out of your investment and increase your productivity.

See demonstrations of our PharmaCare™ equipment at Interphex booth#3532 or our newly opened Technical Support Center in Fort Myers, Florida.

New Products
and Releases
New Whitepapers

iHolland Tablet Tooling

Case Study ‘Pfizer Anti-Stick Trials
I Holland Multi Tip Tooling Research Document ‘Atomic Force Microscopy Anti-Sticking Research’
I Holland PharmaCareTM 7-Step Process  

 

 

For more information:

info@iholland.co.uk

 



ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
8%
Protecting the supply chain
40%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here